Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccination cohort study in immunocompromised and healthy travelers
NL-OMON38641Withdrawn
- Sponsor
- Erasmus MC
- Start
- Feb 2014
- Countries
- 1
01
Overview
Open-label trial in travel-acquired infection (2 arms), sponsored by Erasmus MC. Primary endpoints: Primary endpoint: antibody titer after vaccination and Primary endpoint: incidence of infectious diseases during travel. Planned start Feb 2014; status: withdrawn.
02
Conditions
travel-acquired infection
Beyond the preview
Go deeper on NL-OMON38641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38641.